Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
M Charabati, MA Wheeler, HL Weiner, FJ Quintana - Cell, 2023 - cell.com
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central
nervous system afflicting nearly three million individuals worldwide. Neuroimmune …
nervous system afflicting nearly three million individuals worldwide. Neuroimmune …
[HTML][HTML] Multiple sclerosis: mechanisms and immunotherapy
C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - cell.com
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …
B cells in autoimmune and neurodegenerative central nervous system diseases
B cells are essential components of the adaptive immune system and have important roles
in the pathogenesis of several central nervous system (CNS) diseases. Besides producing …
in the pathogenesis of several central nervous system (CNS) diseases. Besides producing …
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell… - Annals of …, 2011 - Wiley Online Library
New evidence and consensus has led to further revision of the McDonald Criteria for
diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of …
diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of …
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
L Mayo, SA Trauger, M Blain, M Nadeau, B Patel… - Nature medicine, 2014 - nature.com
Astrocytes have complex roles in health and disease, thus it is important to study the
pathways that regulate their function. Here we report that lactosylceramide (LacCer) …
pathways that regulate their function. Here we report that lactosylceramide (LacCer) …
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39
ID Mascanfroni, A Yeste, SM Vieira, EJ Burns… - Nature …, 2013 - nature.com
Dendritic cells (DCs) control the balance between effector T cells and regulatory T cells in
vivo. Hence, the study of DCs might identify mechanisms of disease pathogenesis and guide …
vivo. Hence, the study of DCs might identify mechanisms of disease pathogenesis and guide …
Potassium channel KIR4. 1 as an immune target in multiple sclerosis
R Srivastava, M Aslam, SR Kalluri… - … England Journal of …, 2012 - Mass Medical Soc
Background Multiple sclerosis is a chronic inflammatory demyelinating disease of the central
nervous system. Many findings suggest that the disease has an autoimmune pathogenesis; …
nervous system. Many findings suggest that the disease has an autoimmune pathogenesis; …
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis
A Yeste, M Nadeau, EJ Burns… - Proceedings of the …, 2012 - National Acad Sciences
The immune response is normally controlled by regulatory T cells (Tregs). However, Treg
deficits are found in autoimmune diseases, and therefore the induction of functional Tregs is …
deficits are found in autoimmune diseases, and therefore the induction of functional Tregs is …
Tolerogenic nanoparticles suppress central nervous system inflammation
Therapeutic approaches for the induction of immune tolerance remain an unmet clinical
need for the treatment of autoimmune diseases, including multiple sclerosis (MS). Based on …
need for the treatment of autoimmune diseases, including multiple sclerosis (MS). Based on …
[HTML][HTML] Inflammation, demyelination, and degeneration—recent insights from MS pathology
C Stadelmann, C Wegner, W Brück - Biochimica et Biophysica Acta (BBA) …, 2011 - Elsevier
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
which responds to anti-inflammatory treatments in the early disease phase. However, the …
which responds to anti-inflammatory treatments in the early disease phase. However, the …